Region Hovedstadens Apotek
Region Hovedstadens Apotek is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
The DEXA-PSYCH Study: Dexamethasone Repurposing for Moderate to Severe Depression - A Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Trial
Sponsor Region Hovedstadens Psykiatriske
- Start (EU)
- Latest update
- Estimated end
- Not reported
Adalimumab Treatment for Patients with Hidradenitis Suppurativa at high risk of Progressing to Severe Disease: An Unblinded Randomized, Controlled Trial
Sponsor Gentofte Hospital
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Perineural injections of incobotulinumtoxin-A for diabetic neuropathic pain of the lower extremities: A double-blind, randomized, placebo-controlled study (PINBOT)
Sponsor Rigshospitalet
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Region Hovedstadens Apotek?
The 2026-10-09 snapshot links Region Hovedstadens Apotek to 3 distinct CTIS trials. Recorded services include Medicinal product management. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Region Hovedstadens Apotek?
The most frequently recorded therapeutic areas are Psychiatry. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Region Hovedstadens Apotek conducted?
The linked trials record locations in 1 country, including Denmark. These are trial locations, not confirmed office locations or countries where Region Hovedstadens Apotek delivered services.
What can this page tell me about Region Hovedstadens Apotek's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Region Hovedstadens Apotek. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Region Hovedstadens Apotek